VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma

VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma

http://www.wikidata.org/entity/Q35908666

about

Identification of cisplatin-binding proteins using agarose conjugates of platinum compounds A non-canonical role of the p97 complex in RIG-I antiviral signaling Withaferin A Analogs That Target the AAA+ Chaperone p97.Aberrant regulation of FBW7 in cancer.Cytokine profiling in patients with VCP-associated disease.miR-129 as a novel therapeutic target and biomarker in gastrointestinal cancer Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia.Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.Down-regulation of miR-129-5p inhibits growth and induces apoptosis in laryngeal squamous cell carcinoma by targeting APC.Interferon-β induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells.Proteomic analysis of proton beam irradiated human melanoma cells Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation.Inhibitors of the AAA+ chaperone p97 MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition.Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation Role of microRNAs in inflammation-associated liver cancer AAA-ATPase p97 suppresses apoptotic and autophagy-associated cell death in rheumatoid arthritis synovial fibroblasts.Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.Modulation of immune responses following solid organ transplantation by microRNA.Therapeutic microRNAs targeting the NF-kappa B signaling circuits of cancers.Non-Coding RNAs in Primary Liver Cancer.MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1.Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.Demethylation-mediated miR-129-5p up-regulation inhibits malignant phenotype of osteogenic osteosarcoma by targeting Homo sapiens valosin-containing protein (VCP).miR-129-1-3p promote BGC-823 cell proliferation by targeting PDCD2.miR-129-1-3p inhibits cell migration by targeting BDKRB2 in gastric cancer.MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET.Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial-mesenchymal transition by targetting PMEL through the Wnt signaling pathway.Nuclear paraspeckle assembly transcript 1 promotes the metastasis and epithelial-mesenchymal transition of hepatoblastoma cells by inhibiting miR-129-5p.Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.microRNA-129-5p, a c-Myc negative target, affects hepatocellular carcinoma progression by blocking the Warburg effect.Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.MicroRNA-129-5p inhibits 3T3-L1 preadipocyte proliferation by targeting G3BP1

P2860

Q28533598-AE6CED51-8A45-426D-89E9-3946CD896767 Q28596603-DB538BCF-9074-4672-B271-FBECF0FB9EA1 Q33360763-75124B28-1BFA-4C9F-B2AF-176AFBF186C8 Q33688508-3D52CB37-1B44-4137-9387-C89E1F5FC532 Q33755214-87C3E491-8FEC-4B03-A595-3AEB58365944 Q34109826-28D2BB1D-9922-4CB3-96F1-7E442BDFECCE Q34599349-3CC8CD76-4092-4262-A697-92B12CABD0D4 Q34973811-459B4BFC-0141-458C-9DA7-79EB00D9B0BB Q35032477-BC96DAF1-42AD-4919-8BC3-AB146ABB5361 Q35072497-D3EAD8B0-0512-455B-914A-2E54EF2FCFA8 Q35083440-1F0F01D1-3EFC-43F0-9E89-E4C08D3AF293 Q35181245-4564C40B-1BF0-4543-83DD-0F3D3458F8B0 Q35197356-7AF851D3-3A9A-4123-9AB9-0ABD4CF54B1B Q35981607-56F3A95A-4DFE-4E69-871C-FB4681970187 Q36078289-749930B3-3E6C-41D8-9504-A96D3C478CDC Q36186458-E49450D6-257D-4B12-B55D-EDD3649FB53B Q36544114-8A582ED4-06CA-412E-885A-D88C1438624F Q37069517-00F00754-4068-42F7-A40C-5A9EFA20067A Q37596666-1693BDAB-9B5B-462F-8F94-6509A59421ED Q37665634-597E6E71-AAD8-4B2B-B8D1-BA7DB8F27151 Q37718481-BF6C9826-FF3E-413C-9A24-9C4DA6D7AE43 Q38049411-24A234AE-A89C-42C5-9FBF-7FDF2661D75E Q38249091-B7E31BFF-99F5-4E7C-9653-BB03A8C99AFB Q38541359-437066F9-69F9-4599-A41A-609777A2EADA Q38797965-63824705-C424-4980-9521-2F0627B49FBD Q38839833-F6FBB56D-CCEA-4A98-93B3-C1D92CBD35AD Q38922378-7CC34106-5F2F-4483-A70A-0E1C72A09F69 Q38967155-0300FE16-A4D7-4243-923D-1DF15FEDF899 Q38976892-79EAED25-6A42-401A-B08E-F6185D8A08FF Q39015324-B209672E-BBCC-4E9B-BB6E-BF4935D61C12 Q41622293-0DA6EDB6-FAD6-48EB-A5E3-B987306A34F3 Q50119880-620823EB-B3BC-4F1D-8461-DB42595FEAC1 Q50991345-A81CB800-C0FD-4C7A-B7CC-DE96F71185F1 Q53181847-7DD8A083-CAA5-4BB9-A875-231BA19ACF66 Q55401749-3DA355D0-492B-45C7-AB1C-5E601C680F79 Q58247057-4AFEB56E-DA76-4D2E-9EBE-B3AC196426D0

P2860

VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma

http://www.wikidata.org/entity/Q35908666

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

VCP/p97, down-regulated by mic ...... on of hepatocellular carcinoma

@ast

VCP/p97, down-regulated by mic ...... on of hepatocellular carcinoma

@en

type

label

VCP/p97, down-regulated by mic ...... on of hepatocellular carcinoma

@ast

VCP/p97, down-regulated by mic ...... on of hepatocellular carcinoma

@en

prefLabel

VCP/p97, down-regulated by mic ...... on of hepatocellular carcinoma

@ast

VCP/p97, down-regulated by mic ...... on of hepatocellular carcinoma

@en

P1433

Q35908666-CF9F7DE9-E282-4513-A7E8-B3E558BC17AE

P1476

Q35908666-F4B081AA-1B05-49AE-ABB9-A68488EAB909

P2093

Q35908666-061A16A6-692F-4410-AF30-D5BCA81AB771

Q35908666-14629B25-ABA6-4FD4-8A7A-948D523A72E5

Q35908666-19B6B0AF-86AE-497E-8D99-EAD282D69238

Q35908666-28C0759C-205F-4346-ABA4-39C4A9D3CEFB

Q35908666-AB868324-B333-42AF-9BCD-D29ECB38CCB9

Q35908666-C2BDF5D4-0846-4371-80F9-27D1BB110CF7

Q35908666-D0980039-90EE-49F9-B7BF-487B1DE53C20

P2860

Q35908666-01A60C0A-30E7-436B-AC80-FA1583D31F1E

Q35908666-04772BFE-0A75-4988-8700-80FAEE4BDA58

Q35908666-10ADDBD5-7656-41EC-ADED-5FDD0CAADD7E

Q35908666-12CCC26A-2473-4CC3-9351-B219F08ECB59

Q35908666-163B3DCF-4881-4D21-9EFA-C55321547BDB

Q35908666-16F92949-B3AA-45F7-9A7F-EF9C2B9375AD

Q35908666-1AF3BABD-F2FB-4B95-9848-C2967BCA7BE5

Q35908666-1DE3EDBF-25C1-4C5F-A421-422A41A64FFA

Q35908666-2C0B473A-3A2E-46AA-B103-F3088BAA5868

Q35908666-398EF1DC-75D8-4CE0-AEE2-0A120B74F1A1

P304

Q35908666-012DD5B1-FBCB-469D-B722-E9A73AB53E98

P31

Q35908666-EC492C12-08FF-4DF0-826A-478D6AF0F7C0

P356

Q35908666-A70F83E7-57C5-4DC9-8676-680AC608195E

P407

Q35908666-47B112A3-C5E7-499E-A143-CADEFB2C149F

P433

Q35908666-BE02B519-34F7-432B-AE7C-B975FC20C4C4

P478

Q35908666-5C794E39-9DD2-4490-973B-9EDB302B7DC2

P50

Q35908666-E608E0C3-15F5-4501-A11C-90337F946AC5

P577

Q35908666-793126A9-7D46-4D90-9C51-51BF6C0C39C9

P5875

Q35908666-F0243914-DC34-483F-A3A5-DDADF4C98A22

P698

Q35908666-0443BF45-6404-4F29-AE47-E45BF1BE195F

P921

Q35908666-D402E2E6-6B16-4585-ABB6-A8E63C9228AC

P932

Q35908666-787B6841-2060-47DB-BCAF-38D4E5EAFE35

P356

JOURNAL.PONE.0035800

P1433

P1476

VCP/p97, down-regulated by mic ...... on of hepatocellular carcinoma

@en

P2093

Guang Yang

http://www.w3.org/2001/XMLSchema#string

Jie Dong

http://www.w3.org/2001/XMLSchema#string

Qingming Shu

http://www.w3.org/2001/XMLSchema#string

Xiaofei Zheng

http://www.w3.org/2001/XMLSchema#string

Yan Hei

http://www.w3.org/2001/XMLSchema#string

Yaping Gao

http://www.w3.org/2001/XMLSchema#string

Yu Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation

Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer

MicroRNA expression, survival, and response to interferon in liver cancer

MicroRNAs: small RNAs with a big role in gene regulation

Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma

AAA+ superfamily ATPases: common structure--diverse function

VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line

miR-129 regulates cell proliferation by downregulating Cdk6 expression

P304

e35800

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0035800

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224847885

http://www.w3.org/2001/XMLSchema#string

P698

22536440

http://www.w3.org/2001/XMLSchema#string

P921

P932

3335000

http://www.w3.org/2001/XMLSchema#string